Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Anchorage. Study-provided care at no cost to qualified participants.
Access pancreatic cancer specialists in Anchorage at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
This phase II trial studies whether adding pembrolizumab to olaparib (standard of care) works better than olaparib alone in treating patients with pancreatic cancer with germline BRCA1 or BRCA2 mutations that has spread to other places in the body (metastatic). BRCA1 and BRCA2 are human genes that produce tumor suppressor proteins. These proteins help repair damaged deoxyribonucleic acid (DNA) and, therefore, play a role in ensuring the stability of each cell's genetic material. When either of t
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this pancreatic cancer clinical trial in Anchorage, AK
If you're searching for pancreatic cancer treatment options in Anchorage, AK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anchorage research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.